ABVC BioPharma shares are trading lower after the company priced $1.75 million registered direct offering of 500,000 shares at $3.50/share.
Portfolio Pulse from Benzinga Newsdesk
ABVC BioPharma has priced a registered direct offering of 500,000 shares at $3.50/share, raising $1.75 million. This has led to a decrease in the company's share price.
July 27, 2023 | 4:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ABVC BioPharma's share price is expected to be negatively impacted in the short term due to the pricing of its direct offering.
The company's decision to price a direct offering of 500,000 shares at $3.50/share, below the current market price, has led to a decrease in its share price. This is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100